SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-092702
Filing Date
2020-08-10
Accepted
2020-08-10 16:02:04
Documents
97
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q fbio-20200630x10q.htm   iXBRL 10-Q 4088403
2 EXHIBIT 31.1 fbio-20200630xex31d1.htm EX-31.1 13856
3 EXHIBIT 31.2 fbio-20200630xex31d2.htm EX-31.2 14558
4 EXHIBIT 32.1 fbio-20200630xex32d1.htm EX-32.1 8219
5 EXHIBIT 32.2 fbio-20200630xex32d2.htm EX-32.2 8174
  Complete submission text file 0001104659-20-092702.txt   14732456

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fbio-20200630.xsd EX-101.SCH 102398
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20200630_cal.xml EX-101.CAL 77431
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20200630_def.xml EX-101.DEF 338154
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20200630_lab.xml EX-101.LAB 645233
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20200630_pre.xml EX-101.PRE 586812
11 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20200630x10q_htm.xml XML 3283634
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 201089258
SIC: 2834 Pharmaceutical Preparations